Previous 10 | Next 10 |
The S&P 500 is potentially on track for the greatest year in market history and is 30% historically overvalued. But for those with the right watchlists and tools, Buffett-style "fat pitch" deals are always available. Today Amazon, Bristol Myers, Organon, and BorgWarner represe...
Berkshire Hathaway's 13F stock portfolio value increased from $270.44B to $293.02B this quarter. Their largest three holdings are at ~64% of the entire portfolio. Berkshire Hathaway increased Kroger while reducing Merck and Liberty Global during the quarter. For further deta...
On its Q2 earnings report, Organon hit all the milestones needed to move the stock out of its post-spin doldrums. Data given this quarter should alleviate bear concerns around leverage, revenue declines, growth strategy, dividend, and FCF. With P/E and P/FCF multiples at 5-6x, EV/...
Benjamin Graham is known for developing a fairly complex set of rules and formulas to determine a stock’s intrinsic value. In his final year, Graham offered a much simpler means of finding value, but these simple value comparison tools are often overlooked by many investors. ...
Organon & Co (OGN) Q2 2021 Earnings Conference Call August 12, 2021 8:30 AM ET Company Participants Jennifer Halchak – Vice President of Investor Relations Kevin Ali – Chief Executive Officer Matt Walsh – Chief Financial Officer Conference Call Participants Terence Fl...
The following slide deck was published by Organon & Co. in conjunction with their 2021 Q2 earnings call. For further details see: Organon & Co. 2021 Q2 - Results - Earnings Call Presentation
Second quarter 2021 revenue of $1,595 million Net income from continuing operations of $431 million, or $1.70 per diluted share; Adjusted net income from continuing operations of $437 million, or $1.72 per diluted share Adjusted EBITDA of $627 million Board of Directors de...
AZEK,AZUL,BIDU,BR,CELH,CSIQ,CYBR,EYE,GDRX,GRWG,IQ,KELYA,MDP,MIDD,MSGS,OGN,PLTR,SDGR,TAL,UTZ,ZNTL For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings before Thursday's open
Kahn Brothers’ 13F portfolio value increased from $646M to $698M this quarter. BP plc and Pfizer were increased, while decreasing Nam Tai Property and BlackBerry during the quarter. The portfolio continues to be very concentrated with the top five positions accounting for ~...
TolikoffPhotography/iStock via Getty Images Organon (OGN) and ObsEva (OBSV) have entered into an agreement whereby Organon will license the global development, manufacturing and commercial rights to ebopiprant (OBE022), being evaluated as a potential treatment for preterm labor by reducing in...
News, Short Squeeze, Breakout and More Instantly...
VANCOUVER, BC / ACCESSWIRE / July 24, 2024 / (TSXV:OGN)(OTCQX:OGNRF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce updates for its partner funded exploration stage projects and royalties. Highlights Estimated 30,000 metres of drilling in seven planned or comp...
Company estimates $15 million of milestone expense in the second quarter Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, will release its second quarter 2024 financial results on August 6, 2024, prior to the company’s webcast and conference...
2024-06-08 06:50:00 ET Not all dividend stocks are equal. Some are safer than others. Some have much higher dividend yields than others. When a stock offers both advantages, it's usually a keeper. Three Motley Fool contributors have found stocks with mouthwatering dividends that you...